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Abstract: The Golgi organelle duplicates its protein and lipid content to segregate evenly between two
daughter cells after mitosis. However, how Golgi biogenesis is regulated during interphase remains
largely unknown. Here we show that messenger RNA (mRNA) expression of GOLPH3 and GOLGA2,
two genes encoding Golgi proteins, is induced specifically in G1 phase, suggesting a link between cell
cycle regulation and Golgi growth. We have examined the role of E2F transcription factors, critical
regulators of G1 to S progression of the cell cycle, in the expression of Golgi proteins during interphase.
We show that promoter activity for GOLPH3, a Golgi protein that is also oncogenic, is induced by E2F1-3
and repressed by E2F7. Mutation of the E2F motifs present in the GOLPH3 promoter region abrogates
E2F1-mediated induction of a GOLPH3 luciferase reporter construct. Furthermore, we identify a critical
CREB/ATF element in the GOLPH3 promoter that is required for its steady state and ATF2-induced
expression. Interestingly, depletion of GOLPH3 with small interfering RNA (siRNA) delays the G1 to
S transition in synchronized U2OS cells. Taken together, our results reveal a link between cell cycle
regulation and Golgi function, and suggest that E2F-mediated regulation of Golgi genes is required for
the timely progression of the cell cycle.
Keywords: cell cycle; E2F factors; Golgi; GOLPH3; CREB/ATF; gene regulation
1. Introduction
The Golgi complex is an essential organelle in the secretory pathway, in which newly synthesized
proteins and lipids undergo posttranslational modifications, and are subsequently sorted to their target
locations. The Golgi complex consists of a stack of densely packed and flattened cisternal membranes.
Stacks are commonly interconnected and form a ribbon-like structure that resides close to the nucleus.
A large body of evidence has shown that the Golgi apparatus is dynamic and is able to disassemble
and reassemble under a variety of stress conditions or during cell division cycles through mechanisms
that are not well understood [1–3].
As the cell progresses through the interphase of the cell cycle, the Golgi apparatus, like other
organelles, must duplicate in content and in size before its correct partitioning into daughter cells [1,4].
This process appears to be tightly coupled to cell growth, and probably involves a complex interplay
between extracellular signals and intracellular transcriptional and posttranscriptional networks that
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induce expression of genes encoding organellar proteins. However, how this process occurs and is
regulated remains largely unknown.
A detailed cell synchronization analysis at various cell cycle phases has shown that continuous
Golgi growth and cell size growth are initiated at late G1 to reach a near doubling at the end of G2
phase [4], coinciding with increasing protein translation of some Golgi components, such as the Golgi
structural protein GOLGA2 (GM130) and the Golgi enzyme MAN2A2 (MannII). The kinase S6K1,
whose levels are increased at late G1 phase, is thought to mediate a rise in Golgi protein content [4].
In addition to translational control of Golgi-specific protein production, there is some evidence for
transcriptional regulation [5,6].
Major regulation of timely gene expression during G1-to-S progression is carried out by the
E2F family of transcription factors (E2F1-8). According to the currently accepted model of cell cycle
regulation, in quiescent cells, the transcription of genes required for cell cycle entry and progression is
repressed by complexes formed by hypophosphorylated Retinoblastoma-family (Rb) of proteins bound
to E2F factors [7], together with a large number of chromatin modifying components. The repressor
complexes, which can be formed by different members of the E2F family [8,9], are disrupted upon
phosphorylation of Rb pocket proteins by Cyclin/CDK complexes upon entry into the G1 phase.
Consequently, free E2F is able to induce the expression of genes necessary for DNA replication and
cell cycle progression [10]. Whether E2Fs are involved in regulating the expression of components
of cellular organelles such as those residing in the Golgi complex remains to be determined. Given
the timely regulation of Golgi growth during the cell cycle, we analyzed the impact of cell cycle
regulatory mechanisms on the expression of genes encoding Golgi-specific proteins. We find that
GOLPH3 expression is regulated by E2F factors through E2F motifs present in its promoter. Moreover,
we identify a critical CREB/ATF element in the GOLPH3 promoter that is required for its steady
state as well as ATF-induced expression. Our findings uncover a transcriptional regulation of genes
encoding Golgi-specific proteins, and present evidence suggesting that the coordinated action of
nuclear and Golgi components is necessary for the timely progression of the cell cycle.
2. Materials and Methods
2.1. Cell Culture and Flow Cytometry
Human U2OS osteosarcoma and mouse NIH 3T3 fibroblast cell lines were maintained in Dulbecco’s
modified Eagle’s medium supplemented with fetal bovine serum (10%). For cell synchronization at
mitosis, U2OS cell cultures were incubated with thymidine (2 nM) for 20 h. Subsequently, cells were
washed and cultured for an additional 15 h in fresh medium. Nocodazole (50 ng/mL) was added to the
cultures for the last 10 h. Mitotic cells were collected by shaking off the plates and seeded in complete
medium for subsequent analyses. For cell synchronization at G0, NIH3T3 cells were incubated for
48 h with Dubelcco’s modified Eagle’s medium supplemented with 0.1% fetal bovine serum. After G0
synchronization, cells were collected at different times for subsequent analysis.
To assess cell-cycle distribution, cells were fixed with chilled 70% ethanol, stained with 50 µg/mL
propidium iodide (PI) and analyzed by flow cytometry (FACSCalibur, BD). The analyses of generated
data were performed with Summit 4.3 software.
2.2. Plasmid Description
Mammalian expression plasmids pRc-CMV-HA-E2F1, pRc-CMV-HA-E2F2, pRc-CMV-HA-E2F3
have been previously described [11]. Plasmid pCMV6-XL5-E2F7 was purchased from Origene.
Plasmids pATF2-HA and p∆-ATF2-HA were kindly provided by Dr. Lazo-Zbikowski. To construct the
wild-type pGL2-GOLPH3Promoter-luc (pGP3-WT-luc) reporter plasmid, 488 bp (−254 to +234) of the
human GOLPH3 promoter region was amplified by PCR using human genomic DNA as template (See
Supplementary Table S1 for primer sequence information). PCR product was digested with MluI and
HindIII and cloned into the pGL2-basic luciferase reporter vector (Promega).
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DNA fragments encoding GOLPH3 promoter deletion mutants lacking the upstream region
(pGP3-∆UR-luc), the downstream region (pGL2-GP3-∆DR-luc) or containing only a minimal region
(pGP3-MR-luc) were amplified by PCR using the pGP3-WT-luc vector as template. PCR products were
digested with MluI and HindIII and ligated into pGL2-basic vector to generate the corresponding
pGP3-WT deletion mutant.
Site-directed mutagenesis of the CREB/ATF motifs in pGP3-WT-luc reporter plasmid was
carried out using the QuickChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies),
following the manufacturer’s directions. Briefly, forward and reverse mutagenic primers containing
mutated nucleotides (See Supplementary Table S2 for nucleotide sequences of the primer sets used for
mutagenesis) were used to PCR amplify pGP3-WT-luc plasmid. Subsequently, parental DNA digested
with DpnI and remaining plasmid was transformed into competent cells for nick repair. The resulting
plasmid was named pGP3-CREBm-luc.
Site-directed mutagenesis of the two E2F motifs in pGP3-WT-luc reporter plasmid was carried
out using the QuickChange Multi Site-Directed Mutagenesis Kit (Agilent Technologies), following the
manufacturer’s directions. Briefly, two mutagenic forward primers were used to synthesize the mutant
strand using pGP3-WT-luc as template. After DpnI digestion of template strand, mutant ssDNA strand
was transformed into XL10 Gold competent cells. The resulting plasmid was named pGP3-E2Fm-luc.
Site-directed mutagenesis of the triple mutant for E2F and CREB/ATF motifs was carried out
using pGP3-E2Fm-luc as template and CREB forward and reverse mutagenic primers, as indicated
above. The resulting plasmid was named pGP3-3xm-luc.
The orientation and integrity of all constructions were confirmed by DNA sequencing.
2.3. Transfections and siRNA-Mediated Knockdown
Plasmid transfection was performed with various amounts of DNA in 6-well or 12-well culture
dishes using XtremeGENE HD (Roche Pharma, Basel, Switzerland) transfection reagent following
manufacturer’s recommendations. The mixture was incubated for 25 min at room temperature and
added dropwise to cell cultures.
For knockdown of endogenous GOLPH3 [12], commercial small interfering RNA (siRNA)
oligonucleotides (Life Technologies, Carlsbad, CA, USA) were transfected at a final concentration of 7.5 nM
using Lipofectamine RNAiMAX (Life Technologies) following the manufacturer’s recommendation.
2.4. Luciferase Activity Assay
For luciferase activity assays in asynchronous cells, U2OS cells were plated at a density of
2 × 105 cells/well on a six-well plate, and 24 h later, cotransfected with 500 ng of the firefly luciferase
reporter vector, 20 ng of the Renilla luciferase reporter vector (pRL-TK) and varying amounts of
expression plasmids. The total amount of DNA in the reaction mixtures was brought to 1 µg using
pCMV vector. Using the Dual-Luciferase Reporter Assay System (Promega, Madison, WI, USA),
the reporter firefly luciferase activity was measured 24 h or 48 h after transfection, following the
manufacturer’s recommendations. Data were normalized to the transfection efficiency estimated by the
activity of Renilla luciferase in each sample, obtaining Relative Luciferase Units (RLU). The luciferase
activity measured in cells transfected only with reporter vector was used as a reference to calculate
fold induction.
For luciferase activity assays with synchronized U2OS cells, the transfections were carried out
after washing cells following incubation with thymidine (2 nM) for 20 h. Subsequently, cells were
cultured for an additional 15 h in fresh medium. Nocodazole (50 ng/mL) was added to the cultures for
the last 10 h. Mitotic cells were collected by shaking off the plates and cultured in complete medium
for subsequent luciferase assays.
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2.5. RNA and Protein Expression Analyses
Total RNA extraction was performed with TRIzol Reagent (Life Technologies) and purified using
the RNeasy Mini kit (Qiagen, Hilden, Germany) following the manufacturer’s recommendations. RNA
was reverse-transcribed into cDNA with the High-Capacity cDNA RT Kit (Life Technologies) and
qPCR was performed as described previously [13], following Minimal Information for Publication of
Quantitative Real-Time PCR Experiments (MIQE) guidelines. Briefly, qPCR was performed on several
cDNA dilutions plus 1 × SYBR green PCR Master Mix (Applied Biosystems, Foster City, CA, USA)
and 300–900 nM of primers for the analyzed genes (sequences are listed in Supplementary Table S3).
Reactions were carried out in triplicate using QuantStudio 3 (Applied Biosystems) thermocycler for
40 cycles (95 ◦C for 15 s and 60 ◦C for 1 min) after an initial 10-min incubation at 95 ◦C. Relative
amounts of cDNA were normalized to the internal control EIF2C2, whose levels were invariant in all
the analyzed conditions.
For western blot analyses, cells were lysed in buffer containing 10 mM NaPO4 H, pH 7.2; 1 mM
EDTA; 1 mM EGTA; 150 mM NaCl; 1% NP-40 and a cocktail of protease and phosphatase inhibitors
(Roche). Protein concentrations in supernatants were determined using a commercially available
kit (DC Protein Assay from Bio-Rad, Hercules, CA, USA). Twenty to thirty micrograms of protein
were loaded per lane, fractionated in 10–12% SDS-PAGE gels and transferred onto nitrocellulose
membranes (Bio-Rad), as described previously [13]. Antibodies against the following proteins were
used: E2F1 (sc-193, Santa Cruz), E2F2 (sc-633, Santa Cruz, Dallas, TX, USA), E2F3 (sc-878, Santa Cruz),
GOLPH3 (ab91492, Abcam, Cambridge, UK), α-Tubulin TUBA4A (T-9026, Sigma, Saint Louis, MO,
USA). Immunocomplexes were visualized with horseradish peroxidase-conjugated anti-rabbit IgG
antibodies (Santa Cruz), followed by chemiluminiscence detection (ECL, Amersham) with a ChemiDoc
camera (Bio-Rad).
2.6. Bioinformatic Tools
Search for transcription factors motifs in GOLPH3 gene promoter was carried out with the ConSite
web-based tool for finding cis-regulatory elements in genomic sequences (http://consite.genereg.net/).
The search was restricted to the proximal promoter region (−500 and +250 relative to the transcriptional
star site). A cutoff of 0.80 was applied.
2.7. Statistical Analysis
Data are presented as mean ± standard deviation (SD). The significance of the difference
between two groups was assessed using the Student two-tailed t-test. p < 0.05 was considered
statistically significant.
3. Results
3.1. Cell Cycle Regulation of Golgi-Specific Gene Expression
The Golgi complex undergoes organelle growth during G1 through S phase of the cell cycle [4].
We reasoned that transcription of Golgi-specific genes may be similarly regulated during the cell
cycle, to duplicate all the Golgi components in a timely fashion before cell division. To test this
hypothesis, we synchronized U2OS cells in mitosis through a treatment with thymidine followed by
nocodazole, as shown in Figure 1A. Cells were subsequently released from mitotic block and cultured
in drug-free medium. At several time points, entry and progression of the cells through G1 and into S
was confirmed by flow cytometry (Figure 1B), and by assessing the messenger RNA (mRNA) levels of
E2F1 and CYCE1 (Figure 1C), two cell cycle-regulated genes whose expression is induced in G1 and in
S-phase, respectively.
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Expression values were normalized to the expression of EIF2C2, used as standard control. Data 
are represented as fold-change (mean + SD) relative to samples synchronized in mitosis (0h). 
Shown are the results of one representative experiment of three independent experiments. (E) 
RT-qPCR analysis of mouse GOLPH3 mRNA. Mouse NIH 3T3 cells that had been synchronized 
in G0 by serum starvation were released into the cell cycle after serum addition. RNA samples 
were collected at the indicated time-points. Expression values were normalized to the 
expression of EIF2C2, used as standard control. Graph represents the relative expression values 
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Figure 1. Expression of genes encoding Golgi-specific proteins in the cell cycle. (A) As shown in the
schematic diagram, U2OS cells that had been treated with thymidine (Thy) for 20 h were washed
and 5 h later wer treated with no azole (Noco) for 10 h o synchronize in mitosis. Subseque tly,
cells were release into the cell cy le and collected at h in icated time-points for cell cycle profiling
and RNA analysis. (B) Table showing the per entage of cells in each cell cycle phase at the indicated
time-points, as ass ssed by FACS analysis of PI-stained cells. (C,D) Reverse trans riptase-quantitative
PCR (RT-qPCR) ana yses of indicated genes is shown. Expression values were normalized to the
expression of EIF2C2, used as standard control. Data are represented as fold-change (mean + SD)
relati to samples synchronized in mitosis (0 h). Shown are the results of one representative experiment
of three independent exp riments. (E) RT-qPCR analysis of mouse GOLPH3 mRNA. Mouse NIH 3T3
cells that had b en ynchronized in G0 by serum starvation were released nto the cell cycle after
serum addition. RNA samples were collected at the indicated time-points. Expr ssion values were
normalized to the expression of EIF2C2, used as standard control. Graph represents the relative
expression val es of GOLPH3 messeng r RNA (mRNA) r l tive to cells in G0 (0 h). (F) Western
analysis of thymi ine-nocodazole synchronized U2OS cell showing GOLPH3 expression after rel ase
from mitosis (0 h). *, p < 0.05.
Synchronized RNA samples were used to analyze the expression of several genes coding for
Golgi proteins that are known to have structural or enzymatic function (GOLPH3, GOLGA2, GOLGA5,
MAN2A1). Whereas the expression of GOLGA5 and MAN2A2 remained essentially constant through
G1, the expression of GOLPH3 and GOLGA2 showed a G1-specific induction. Their mRNA levels
were increased moderately but significantly about 1.6- to-1.8-fold in early G1 (Figure 1D), suggesting
that GOLPH3 and GOLGA2 expression is regulated during G1, concomitant with the growth of
Golgi organelle.
To confirm cell cycle-dependent regulation of genes e coding Golgi proteins in another cellular
system, we made use of mouse NIH 3T3 cells that were synchronized in G0 by serum starvation, and
subsequently stimulated with 20% serum to i duce entry of the cells into the cell cycle. We focused
our analysis on GOLPH3, a particularly interesti g Golgi peripheral membrane protein involved
in s cretory trafficking that is oncogenic [3,14,15]. As with U2OS cells synchronized in mitosis by
thymidine- oco azole treatment, the expression of GOLPH3 mRNA was induced in early G1, and was
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reduced as cells entered S-phase (Figure 1E). Cell cycle-regulation of GOLPH3 expression was also
observed at the protein level (Figure 1F).
3.2. GOLPH3 Gene Promoter Activity Is Regulated by E2F Family Members
To explore the mechanism by which GOLPH3 is transcriptionally regulated, we examined the
sequence of the GOLPH3 gene promoter to identify transcription factor motifs that could account for
its cell cycle-regulated expression. A search for cis-regulatory elements in GOLPH3 genomic sequences
with the ConSite tool revealed the presence of two E2F binding sites located in the opposite orientation
(ACGCCAAA and TCTCCCGCG), shown in Figure 2A. Other Golgi-specific gene promoters also
exhibited E2F binding sites in their promoter sequences (Supplementary Figure S1). Furthermore,
ENCODE data extracted from Genome Browser database (https://genome.ucsc.edu/cite.html) showed
detectable E2F binding activity on their promoters (Supplementary Figure S2), which was strong in
the case of GOLPH3, GOLGA5 and MAN2A1, and weak in the case of GOLGA2, thus correlating with
the number of putative E2F sites.
Genes 2019, 10, 247 6 of 15 
cells synchronized in mitosis by thymidine-nocodazole treatment, the expression of GOLPH3 
mRNA was induced in early G1, and was reduced as cells entered S-phase (Figure 1E). Cell 
cycle-regulation of GOLPH3 expression was also observed at the protein level (Figure 1F). 
3.2. GOLPH3 Gene Promoter Activity Is Regulated by E2F Family Members 
To explore the mechanism by which GOLPH3 is transcriptionally regulated, we examined 
the sequence of the GOLPH3 gene promoter to identify transcription factor motifs that could 
account for its cell cycle-regulated expression. A search for cis-regulatory elements in GOLPH3 
genomic sequences with the ConSite tool revealed the presence of two E2F binding sites located 
in the opposite orientation (ACGCCAAA and TCTCCCGCG), shown in Figure 2A. Other Golgi-
specific gene promoters also exhibited E2F binding sites in their promoter sequences 
(Supplementary Figure S1). Furthermore, ENCODE data extracted from Genome Browser 
database (https://genome.ucsc.edu/cite.html) showed detectable E2F binding activity on their 
promoters (Supplementary Figure S2), which was strong in the case of GOLPH3, GOLGA5 and 
MAN2A1, and weak i  the case of GOL A2, thus cor elating with the number of putative E2F 
sites. 
E2F transcription factors are well-known for their role in regulating the timely expression 
of genes necessary for DNA replication and cell cycle progression [10]. However, their role in 
Golgi-specific gene expression has not been explored to date. To determine whether GOLPH3 
expression is regulated by E2F factors, we transfected U2OS cells with plasmids encoding E2F1, 
E2F2 or E2F3, and subsequently synchronized the cells with thymidine-nocodazole. After 
release from mitotic block, cells were collected in early and late G1-phase (6 h and 9 h). RT-qPCR 
and Western analyses of the samples showed a significantly increased expression of GOLPH3 
mRNA in cells overexpressing E2F1-3, compared to co trol cell  transfected with empty v ctor 
(Figure 2B,C), suggesting that GOLPH3 is an E2F responsive gene. 
 
Figure 2. Identification of GOLPH3 regulatory sequences. (A) Schematic representation of 
transcription factor-binding sites in human GOLPH3 regulatory region (−500 to +234). E2F and 
ATF/CREB motifs are indicated as boxes. The transcriptional start site is depicted with an arrow. 
(B) RT-qPCR analysis of GOLPH3 mRNA expression in U2OS cells transfected with plasmids 
encoding E2F1, E2F2 or E2F3 proteins under CMV promoter, synchronized with Thy-Noc and 
subsequently released into the cell cycle. Expression values were normalized to the expression 
of EIF2C2, used as standard control. Data are represented as fold-change (mean ± SD) relative 
A 
-500 +234 
GOLPH3 promoter 
E2F E2F 
CREB/ 
ATF 
CREB/ 
ATF 
CREB/ 
ATF 
B 
pE2F1 pCMV pE2F2 pE2F3 
E2F1 
E2F2 
E2F3 
TUBA4A 
pCMV pE2F1 pE2F2 pE2F3 
GOLPH3 
TUBA4A 
C 
0 
1 
2 
3 
Early G1 phase Late G1 phase  
pCMV  pE2F1  pE2F2  pE2F3  
Re
lat
ive
 G
OL
PH
3 m
RN
A 
lev
els
 
* 
* 
* 
* 
* * 
Figure 2. Identification of GOLPH3 regulatory sequences. (A) Schematic representation of transcription
factor-binding sites in human GOLPH3 regulatory region (−500 to +234). E2F and ATF/CREB motifs
are indicated as boxes. The transcriptional start site is depicted with an arrow. (B) RT-qPCR analysis
of GOLPH3 mRNA expression in U2OS cells transfected with plasmids encoding E2F1, E2F2 or E2F3
proteins under CMV promoter, synchronized with Thy-Noc and subsequently released into the cell
cycle. Expr ssio valu s were normalized to the expression of EIF2C2, used as standard control. Data
are represented as fold-ch ge (mean ± SD) relative to value of cells transfected with mpty pCMV
vector. *, p < 0.05. (C) Western analysis of GOLPH3 protein levels in U2OS cells overexpressing E2F1-3.
Bottom panel shows E2F1, E2F2 and E2F3 protein levels after transfection of each E2F expression
plasmid. Shown are the results of one representative experiment of three independent experiments.
E2F transcription factors are well-known for their role in regulating the timely expression of genes
necessary for DNA replication and cell cycle progression [10]. However, their role in Golgi-specific gene
expression has not been explored to date. To determine whether GOLPH3 expression is regulated by
E2F factors, we transfected U2OS cells with plasmids encoding E2F1, E2F2 or E2F3, and subsequently
synchronized the cells with thymidine-nocodazole. After release from mitotic block, cells were collected
in early and late G1-phase (6 h and 9 h). RT-qPCR and Western analyses of the samples showed
a significantly increased expression of GOLPH3 mRNA in cells overexpressing E2F1-3, compared
to control cells transfected with empty vector (Figure 2B,C), suggesting that GOLPH3 is an E2F
responsive gene.
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To examine transcriptional regulation of the GOLPH3 gene, we amplified a sequence 5′ to the
translational start site of the GOLPH3 gene (+235) from human genomic DNA using PCR, and cloned
the GOLPH3 regulatory region upstream of a luciferase reporter gene, to generate plasmid pGP3-WT-luc
(Figure 3A). This plasmid carries a≈500 bp regulatory sequence of GOLPH3 (−254 bp to +234 bp), which
includes both E2F sites identified bioinformatically. U2OS cells were transfected with pGP3-WT-luc
plasmid or with empty pGL2-luc plasmid, and subsequently synchronized, as detailed above. Luciferase
activity was measured at 0 h (mitosis), 4 h, 8 h and 12 h (G1 to S-phase progression). As shown in
Figure 3B, luciferase activity was barely detectable in mitotic cells, with values close to those gathered for
empty backbone plasmid pGL2. By contrast, luciferase activity increased significantly as cells progressed
through the G1-phase of the following cell cycle, suggesting that the GOLPH3 promoter is responsive to
cell cycle regulatory signals. Furthermore, steady-state levels of GOLPH3 promoter activity were easily
detectable in asynchronous cells, most of which are known to be in G1 (Figure 3C).
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Figure 3. GOLPH3 gene is regulated by E2F factors at the transcriptional level. (A) Promoter-luciferase
construct of GOLPH3. The nucleotide positions of the promoter construct are numbered relative
to the transcription start site. (B) Activation of GOLPH3 promoter-driven firefly luciferase reporter
construct during the cell cycle. U2OS cells were transfected with pGP3 wild type construct (pGP3-WT)
or pGL2 empty construct along with pRL-TK. Cells were subsequently synchronized in mitosis with
Thy-Noc, and released into the cell cycle. Values are represented as firefly luciferase activities relative
to Renilla luciferase activities of each sample. (C) Activation of GOLPH3 promoter-driven construct in
asynchronous cells. Asynchronously growing U2OS cells were transfected with pGP3-WT construct or
pGL2 empty construct along with pRL-TK. Values are represented as firefly luciferase activities relative
to Renilla luciferase activities of each sample. (D) Ectopic E2F1-3 expression induces GOLPH3 promoter
activity. Asynchronously growing U2OS cells were transfected with pGP3-WT and increasing amounts
of E2F1-3 (50 ng, 150 ng, 250 ng) per well in a 12-well plate. Values are represented as luciferase
activities relative to pGP3-WT activity of cells transfected with empty pCMV control. (E) Ectopic
E2F7 expression represses GOLPH3 promoter activity. Asynchronously growing U2OS cells were
transfected with pGP3-WT and increasing amounts of E2F7 (50 ng, 150 ng, 250 ng) in the absence (left
panel), or in the presence of E2F1 co-expression (150 ng). Values are represented as luciferase activities
relative to pGP3-WT activity of cells transfected with empty pCMV control. Shown are the results of
a representative experiment of three independent experiments. *, p < 0.05.
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Given the well-known role of E2F factors as transcriptional regulators, whereby E2F1-3 are thought
to activate gene transcription and E2F7 is thought to repress gene transcription [16,17], we expressed
E2F1-3 factors individually, along with pGP3-WT-luc in U2OS cells. In all three cases, we found
a rise in GOLPH3 promoter activity upon overexpression of E2F1-3 (Figure 3D). By contrast, when
we overexpressed E2F7, alone or in combination with E2F1, the luciferase activity of GOLPH3 was
reduced in a dose-dependent manner (Figure 3E). Taken together, these results suggest that E2F factors
are key regulators of GOLPH3 gene expression at the transcriptional level, and that its regulation is
subject to activation and repression, depending on the particular E2F member that may be expressed
in cells at a given moment.
3.3. Mutational Analysis of GOLPH3 Promoter
To further analyze GOLPH3 transcriptional regulation, we generated several promoter deletion
constructs (Figure 4A). We first eliminated the 250 bp upstream regulatory region relative to the
transcriptional start site, which contained the E2F binding sites, to produce pGP3-∆UR-luc. This deletion
construct, which encompasses the 5′UTR of GOLPH3, was transfected into U2OS cells, along with
increasing doses of E2F1. Luciferase reporter assays showed that this promoter still maintained
a steady-state activity and could be induced during G1-phase, although it was reduced to about half
the activity of the pGP3-WT-luc plasmid (Figure 4B,C). Importantly, this construct was unresponsive
to E2F1 activity, and luciferase values remained similar to those in samples without E2F1 (Figure 4B).
Further deletion of the promoter from −254 to +80 gave rise to plasmid pGP3-MR-luc (Figure 4A). This
construct carrying a minimal piece of the GOLPH3 regulatory region was unable to elicit any luciferase
activity under steady-state conditions or upon ectopic E2F1 expression (Figure 4B). Taken together, these
results suggest that the upstream region of GOLPH3 promoter is important for its optimal transcriptional
activity, and that E2F factors act through this upstream region.
To specifically determine the role of E2F factors in GOLPH3 promoter regulation, we constructed
a plasmid carrying point mutations in both E2F sites (pGP3-E2Fm-luc), which abrogate E2F binding
(Figure 4A and Supplementary Table S2). Interestingly, the activity of the E2F binding site-mutant
GOLPH3 promoter was approximately 1.5 higher than the activity of the wild-type promoter in U2OS
cells (Figure 4C,D), suggesting that these E2F sites can function as negative regulatory elements.Genes 2019, 10  247 9 of 15 
  
Figure 4. E2F binding motifs function as negative and positive regulatory elements. (A) 
Promoter-luciferase constructs of GOLPH3 and its derivatives. Mutant motifs are depicted with 
a white cross. (B) Asynchronous U2OS cells were transfected with the indicated luciferase 
reporter constructs along with pRL-TK and various amounts of a plasmid expressing E2F1 (50 
ng, 150 ng, 250 ng) per well in a 12-well plate. Values are represented as luciferase activities 
relative to pGP3-WT activity of cells transfected with empty pCMV control. (C) U2OS cells were 
transfected with the indicated reporter constructs along with pRL-TK and synchronized in 
mitosis. Subsequently, cells were released into the cell cycle and luciferase values were 
calculated as relative values of firefly luciferase activities relative to Renilla activities in each 
sample. (D) Asynchronous U2OS cells were transfected with the indicated reporter constructs 
and various amounts of a plasmid expressing E2F1 (50 ng, 250 ng). Values are represented as 
luciferase activities relative to pGP3-WT activity of cells transfected with empty pCMV control. 
Shown are the results of a representative experiment of two independent experiments. *, p < 0.05. 
3.4. A CREB/ATF Site in the GOLPH3 Promoter Regulates Steady-State GOLPH3 Expression 
The bioinformatic analysis identified several CREB/ATF motifs in the regulatory region of 
GOLPH3. One motif is located in the region upstream of the transcriptional initiation site, and 
three more are located downstream of it (Figure 2A). To further investigate the transcriptional 
regulation of GOLPH3 gene, we constructed a plasmid lacking the 5′UTR sequence by deleting 
D C 
Re
lat
ive
 Lu
c a
cti
vit
y 
0 
0,5 
1 
1,5 
2 
pG
L2 
GP
3-W
T 
GP
3-W
T + 
E2F
1 10
0 
GP
3-W
T + 
E2F
1 30
0 
GP
3-W
T + 
E2F
1 50
0 
GP
3-D
UR
 
GP
3-D
UR
 + E
2F1
 100
 ng 
GP
3-D
UR
 + E
2F1
 300
 ng 
GP
3-D
UR
 + E
2F1
 500
 ng 
GP
3-D
DR
 
GP
3-D
DR
 + E
2F1
 100
 ng 
GP
3-D
DR
 + E
2F1
 300
 ng 
GP
3-D
DR
 + E
2F1
 500
 ng GP3
 GP3-WT        -     +     +    +     +    
GP3-ΔUR                     +     +     +     +   
GP3-ΔDR                              +     +     +      + 
GP3-MR                                             + 
E2F1                   -                          -                          -    
B 
* * 
* 
* 
* * 
Re
lat
ive
 Lu
c a
cti
vit
y 
0 
1 
2 
3 
4 
5 
6 
7 
WT-LUC E2FMUT-LUC GP3-WT       +   +   +        
GP3-E2Fm               +   +   +        
E2F1                -                      - 
0H             4H               8H              12H 
0 
1 
2 
3 
4 
5 
6 
0H 4H 8H 12H GP3-WT        +   -  -        +  -   -        +  -   -        +   -  - 
GP3-ΔUR      -   +   -         -  +  -        -  +   -        -   +   - 
GP3-E2Fm       -   -   +         -  -  +        -   -   +        -    -   + 
Re
lat
ive
 Lu
c a
cti
vit
y 
* 
* * 
* 
3.1 
6.3 * 
* 
1.6 
1.8 
* 
* 
-254 +234 pGP3-WT 
- 4 +234 pGP3-ΔUR 
-254 +4 pGP3-ΔDR 
+80 +234 pGP3-MR 
-254 +234 pGP3-E2Fm 
A 
.  
 
.  
0 
Figure 4. Cont.
Genes 2019, 10, 247 9 of 15
Genes 2019, 10, 247 9 of 15 
  
Figure 4. E2F binding motifs function as negative and positive regulatory elements. (A) 
Promoter-luciferase constructs of GOLPH3 and its derivatives. Mutant motifs are depicted with 
a white cross. (B) Asynchronous U2OS cells were transfected with the indicated luciferase 
reporter constructs along with pRL-TK and various amounts of a plasmid expressing E2F1 (50 
ng, 150 ng, 250 ng) per well in a 12-well plate. Values are represented as luciferase activities 
relative to pGP3-WT activity of cells transfected with empty pCMV control. (C) U2OS cells were 
transfected with the indicated reporter constructs along with pRL-TK and synchronized in 
mitosis. Subsequently, cells were released into the cell cycle and luciferase values were 
calculated as relative values of firefly luciferase activities relative to Renilla activities in each 
sample. (D) Asynchronous U2OS cells were transfected with the indicated reporter constructs 
and various amounts of a plasmid expressing E2F1 (50 ng, 250 ng). Values are represented as 
luciferase activities relative to pGP3-WT activity of cells transfected with empty pCMV control. 
Shown are the results of a representative experiment of two independent experiments. *, p < 0.05. 
3.4. A CREB/ATF Site in the GOLPH3 Promoter Regulates Steady-State GOLPH3 Expression 
The bioinformatic analysis identified several CREB/ATF motifs in the regulatory region of 
GOLPH3. One motif is located in the region upstream of the transcriptional initiation site, and 
three more are located downstream of it (Figure 2A). To further investigate the transcriptional 
regulation of GOLPH3 gene, we constructed a plasmid lacking the 5′UTR sequence by deleting 
D C 
Re
lat
ive
 Lu
c a
cti
vit
y 
0 
0,5 
1 
1,5 
2 
pG
L2 
GP
3-W
T 
GP
3-W
T + 
E2F
1 10
0 
GP
3-W
T + 
E2F
1 30
0 
GP
3-W
T + 
E2F
1 50
0 
GP
3-D
UR
 
GP
3-D
UR
 + E
2F1
 100
 ng 
GP
3-D
UR
 + E
2F1
 300
 ng 
GP
3-D
UR
 + E
2F1
 500
 ng 
GP
3-D
DR
 
GP
3-D
DR
 + E
2F1
 100
 ng 
GP
3-D
DR
 + E
2F1
 300
 ng 
GP
3-D
DR
 + E
2F1
 500
 ng GP3
 GP3-WT        -     +     +    +     +    
GP3-ΔUR                     +     +     +     +   
GP3-ΔDR                              +     +     +      + 
GP3-MR                                             + 
E2F1                   -                          -                          -    
B 
* * 
* 
* 
* * 
Re
lat
ive
 Lu
c a
cti
vit
y 
0 
1 
2 
3 
4 
5 
6 
7 
WT-LUC E2FMUT-LUC GP3-WT       +   +   +        
GP3-E2Fm               +   +   +        
E2F1                -                      - 
0H             4H               8H              12H 
0 
1 
2 
3 
4 
5 
6 
0H 4H 8H 12H GP3-WT        +   -  -        +  -   -        +  -   -        +   -  - 
GP3-ΔUR      -   +   -         -  +  -        -  +   -        -   +   - 
GP3-E2Fm       -   -   +         -  -  +        -   -   +        -    -   + 
Re
lat
ive
 Lu
c a
cti
vit
y 
* 
* * 
* 
3.1 
6.3 * 
* 
1.6 
1.8 
* 
* 
-254 +234 pGP3-WT 
- 4 +234 pGP3-ΔUR 
-254 +4 pGP3-ΔDR 
+80 +234 pGP3-MR 
-254 +234 pGP3-E2Fm 
A 
.  
 
.  
0 
Figure 4. E2F binding motifs function as negative a d positive regulatory elements. (A) Promoter-luciferase
constructs of GOLPH3 and its derivatives. Mutant motifs are depicted with a white cross. (B) Asynchronous
U2OS cells were transfected with the indicated luciferase reporter constructs along with pRL-TK and
various amounts of a plasmid expressing E2F1 (50 ng, 150 ng, 250 ng) per well in a 12-well plate. Values
are represented as luciferase activities relative to pGP3-WT activity of cells transfected with empty pCMV
control. (C) U2OS cells were transfected with the indicated reporter constructs along with pRL-TK and
synchronized in mitosis. Subsequently, cells were released into the cell cycle and luciferase values were
calculated as relative values of firefly luciferase activities relative to Renilla activities in each sample.
(D) Asynchronous U2OS cells were transfected with the indicated reporter constructs and various amounts
of a plasmid expressing E2F1 (50 ng, 250 ng). Values are represented as luciferase activities relative to
pGP3-WT activity of cells transfected with empty pCMV control. Shown are the results of a representative
experiment of two independent experiments. *, p < 0.05.
We next examined the effect of overexpressing E2F1 in pGP3-E2Fm-luc (Figure 4D). Luciferase
analysis showed that E2F1-mediated activation of this reporter plasmid was significantly reduced
(from 3-fold and 6-fold induction with the wild-type promoter to 1.6-fold and 1.8-fold with the mutant
promoter), suggesting that E2F factors regulate GOLPH3 gene expression through E2F sites located in
its promoter.
3.4. A CREB/ATF Site in the GOLPH3 Promoter Regulates Steady-State GOLPH3 Expression
The bioinformatic analysis identified several CREB/ATF motifs in the regulatory region of
GOLPH3. One motif is located in the region upstream of the transcriptional initiation site, and three
more are located downstream of it (Figure 2A). To further investigate the transcriptional regulation of
GOLPH3 gene, we constructed a plasmid lacking the 5′UTR sequence by deleting the region between +5
and +253 (pGP3-∆DR-luc), as shown in Figure 4A. This plasmid maintains the E2F sites. Surprisingly,
we found that basal transcriptional activity of this deletion construct was reduced dramatically, and
that E2F expression could not induce it (Figure 4B).
CREB/ATF motifs are frequently regulated by growth promoting signals through the recruitment
of members of the CREB/ATF family of transcription factors to these promoter elements [18,19].
We tested whether ATF2 could regulate the activity of the GOLPH3 promoter. To this end, U2OS
cells were transfected with pGP3-WT-luc along with ATF2 or a dominant negative construct of ATF2
(∆-ATF2) that suppresses both DNA binding and transcriptional activation by wild-type ATF2 [20].
Cells overexpressing ATF2 showed a dose-dependent increase in luciferase activity compared to
basal levels (Figure 5B), suggesting that GOLPH3 expression could be regulated through CREB/ATF
sites. Furthermore, the deletion construct carrying the 5′UTR of GOLPH3 and lacking E2F sites
(pGP3-∆UR-luc) still exhibited ATF2-dependent transcriptional activity (Figure 5B). By contrast,
overexpression of ∆-ATF2 did not induce the activity of the GOLPH3 promoter, and inhibited
ATF2-mediated luciferase activity (Figure 5C).
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Figure 5. CREB/ TF binding otifs are critical regulators of GOLPH3 promoter activity. (A)
Promoter-luciferase constructs of GOLPH3 and its derivatives. Mutant motifs are depicted with a white
cross. (B) Asynchronous U2OS cells were transfected with the indicated luciferase reporter constructs
along with pRL-TK and various amounts of a plasmid expressing ATF-2 (150 ng, 300 ng). Values
are represented as luciferase activities relative to pGP3-WT or pGP3-∆UR activity of cells transfected
with empty pCMV control. (C) U2OS cells were transfected with pGP3-WT along with a plasmid
expressing ATF2 (300 ng), a plasmid expressing ∆-ATF2 (300 ng) or both. Values are represented
as luciferase activities relative to pGP3-WT activity of cells transfected with empty pCMV control.
(D) Asynchronous U2OS cells were transfected with the indicated reporter constructs and various
amounts of a plasmid expressing ATF-2 (150 ng, 300 ng). Values are represented as luciferase activities
relative to pGP3-WT activity of cells transfected with empty pCMV control. (E,F) U2OS cells were
transfected with the indicated reporter constructs along with pRL-TK and synchronized in mitosis.
Subsequently, cells were released into the cell cycle and luciferase values were calculated as relative
values of firefly luciferase activities relative to Renilla activities in each sample. Shown are the results
of a representative experiment of two independent experiments. *, p < 0.05.
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Of the four CREB/ATF sites identified in GOLPH3 regulatory region, two of them are overlapping
(between position +6 and +23), and their score for similarity with the canonical motif is higher than
the other two (score of 12 vs. 9, according to values displayed in the ConSite analysis). To more directly
assess the role of the overlapping CREB/ATF motifs, we mutated both sites (Figure 5A). Transfection
of CREB/ATF site mutant in U2OS cells abrogated almost completely the luciferase activity of the
GOLPH3 promoter, and transfection of ATF2 did not increase substantially this activity (Figure 5D).
Similarly, luciferase activity was substantially reduced in synchronized U2OS cells transfected with the
mutant construct (Figure 5E), and transfection with a construct carrying E2F and CREB/ATF motifs
mutated simultaneously resulted in an even further reduced luciferase activity (Figure 5F), suggesting
that the E2F and the overlapping CREB/ATF binding motifs are major regulatory sites in cell cycle
regulation of GOLPH3 expression.
3.5. GOLPH3 is Required for a Timely G1 Progression
Golgi organelle growth is thought to be a required step for cells to progress through a “cell
growth checkpoint” in late G1 [4]. Given our finding of a timely induction of GOLPH3 expression
during G1, we wondered whether changes in GOLPH3 levels would impact cell cycle progression.
To analyze this possibility, we transfected U2OS cells with siRNA molecules specific for GOLPH3 [12]
in order to silence GOLPH3 mRNA expression (Figure 6A). Cells were subsequently synchronized with
thymidine-nocodazole and cell cycle progression was examined by flow cytometry. We consistently
found that depletion of GOLPH3 levels results in an increased percentage of cells in G1 and
a lower percentage of cells in S-phase, suggesting that reduction in GOLPH3 levels delays G1-to-S
progression (Figure 6B). Thus, GOLPH3 emerges as a Golgi constituent protein required for timely cell
cycle progression.
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Figure 6. GOLPH3 expression is necessary for timely G1-phase progression. (A) RT-qPCR and Western
analysis of U2OS cells transfected with non-target control siRNAs (siCTRL) or with siRNAs specific
for GOLPH3 (siGOLPH3). mRNA expression values were normalized to the expression of EIF2C2,
used as standard control. Data are represented as fold-change (mean + SD) relative to siRNA control.
*, p < 0.05. GOLPH3 protein levels were assessed by Western analysis with a specific antibody. (B) U2OS
cells were transfected with control or GOLPH3-specific siRNAs and subsequently synchronized in
mitosis by Thy-Noc treatment. After release of cells into the cell cycle, samples were collected at several
time-points, incubated with PI and cell cycle phases were assessed by FACS analysis. Data represent
the mean ± SD of the fraction of siCTRL or siGOLPH3-transfected cells in G1 or S at each time-point
obtained from three independent experiments. *, p < 0.05.
4. Discussion
During cell division, the Golgi organelle must be accurately segregated into the two daughter
cells. This segregation is achieved through disassembly of the Golgi cisternae when cells enter mitosis
followed by a reassembly of the fragments within each daughter cell after the end of mitosis, through
a process involving a wide array of mediators, including Golgi and cytoskeletal proteins, membrane
tethers, as well as kinases and phosphatases to transmit signals into the Golgi membranes [21].
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Biogenesis of the Golgi apparatus during interphase is less well-studied. There is evidence that the
mammalian Golgi apparatus grows in its protein content and volume throughout the G1 phase in
a manner that correlates well with cell size growth [4]. However, it is unknown whether signals
emanating from the cell cycle regulatory network are conveyed to the Golgi organelle for its regulated
growth during G1. Here we show that the expression of GOLPH3 and GOLGA2, two genes encoding
Golgi proteins, is induced specifically in the G1 phase, suggesting a link between cell cycle regulation
and Golgi growth. Furthermore, we present evidence that E2F transcription factors, critical regulators
of the G1 to S transition of the cell cycle regulate expression of GOLPH3. Thus, E2F factors may
coordinate not only DNA replication, but also Golgi-specific gene expression to contribute to the timely
cell cycle progression.
The genes selected for our initial gene expression analysis (GOLPH3, GOLGA2, GOLGA5 and
MAN2A1) are well-known for their Golgi-specific functions [22]. These genes bear putative E2F sites
in their promoter regions and show detectable E2F binding activity on their promoters. The presence
of E2F sites raised the possibility that these genes that encode Golgi proteins may be regulated in
the cell cycle. However, we found differences in their expression pattern during the G1 to S phase.
GOLPH3 and GOLGA2 clearly exhibit cell cycle regulated expression at the mRNA level. By contrast,
GOLGA5 and MAN2A1 did not show such regulation, suggesting that the E2F elements present in their
promoters are not functional in our experimental system. A more systematic analysis involving several
cell lines and various cell cycle synchronization conditions is needed to determine to what extent
Golgi-specific genes are transcriptionally regulated in the cell cycle. Alternatively, Golgi components
may be regulated at the protein level. There is evidence of posttranscriptional mechanisms regulating
the expression of some Golgi proteins. For example, GOLGA2 and MAN2A1 levels have been shown
to be induced at the translational level during interphase in an S6K1-dependent manner [4]. Thus,
Golgi protein levels appear to be regulated by a combination of cell cycle-regulated transcriptional
and posttranscriptional mechanisms that would ensure the necessary increase of Golgi size before
cell division.
GOLPH3 promoter harbors two putative E2F motifs, and our promoter deletion and mutation
analyses indicate that regulation of GOLPH3 expression by E2Fs is mediated through these E2F sites.
A comparison of GOLPH3 E2F motifs between several mammalian species shows that the proximal
E2F site is more conserved than the distal E2F site (Supplementary Figure S2), suggesting that both
E2F sites may not be functionally equivalent. Mouse and rat GOLPH3 genes only harbor the E2F site
that corresponds to the proximal site in humans, and our data show that mouse GOLPH3 expression is
induced well in G1 phase, similarly to human GOLPH3 gene, which suggests that the proximal E2F
motif may be more functionally active than the distal E2F motif in the human promoter. A mutational
analysis of individual E2F sites may help define more precisely the contribution of each motif to the
regulation of GOLPH3 gene expression.
Similarly to many other E2F-regulated genes, GOLPH3 expression is induced by E2F1-3 and
repressed by E2F7. Gene expression during G1 to S progression is thought to be mediated by a complex
set of regulatory feedback loops established among members of the E2F family [23]. According to
this model, induction of G1 genes by E2F1-3 would subsequently be repressed by the activity of the
repressor arm of the E2F family (E2F6-8), whose own expression follows temporally that of E2F1-3.
Our results suggest that the coordinated action of E2F activators and E2F repressors would ensure
a tightly regulated expression of GOLPH3, and perhaps other genes encoding Golgi proteins, within the
G1 to S window, prior to Golgi dispersal during mitosis. Thus, E2F factors may be major determinants
of Golgi-specific GOLPH3 gene regulation.
Interestingly, the E2F sites themselves function as negative regulatory elements, as shown by the
fact that mutation of E2F motifs leads to an increased basal promoter activity (Figure 4B,C). A similar
type of regulation has been reported for several other E2F target genes, including MYB, E2F1, BRCA1,
and it is thought to result from recruitment of E2F repressor complexes containing Retinoblastoma
family members [24–26]. In this context, GOLPH3 expression would be regulated negatively in G0 or
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early G1 by RB-dependent repression and in S-phase by E2F7-dependent expression, with a window
in G1 that would allow its induction by E2F1-3.
In addition to E2F motifs, our luciferase reporter data indicate that other regulatory elements in
GOLPH3 promoter have a critical role in GOLPH3 expression. Most notably, we have identified four
CREB/ATF binding motifs that are located in its regulatory region. Two overlapping motifs located
adjacent to the transcriptional start site are well conserved in other mammalian genomes, whereas
the other two show greater divergence (Supplementary Figure S3). Mutation of both CREB/ATF
overlapping motifs reduces dramatically steady-state activity of GOLPH3 promoter, suggesting that
these elements are essential for GOLPH3 expression.
The CREB/ATF motif is recognized by proteins of the CREB and ATF families [18]. Members
of these families are structurally similar, but have discrete transcriptional properties that contribute
to their distinct regulatory functions [27]. We presently do not know which individual members are
recruited to CREB/ATF motifs in GOLPH3 promoter to regulate its expression. We find that ectopic
expression of ATF2, a transcription factor that can be activated by growth promoting signals, is able to
induce GOLPH3 promoter activity, suggesting that activation of ATF2 early in G1 could contribute to
the induction of GOLPH3 transcription through its CREB/ATF elements. Nevertheless, individual
silencing of CREB and ATF family members may give a more comprehensive picture of GOLPH3
regulation by these transcription factors, known to be activators or repressors depending on the
cellular context. Of note, some CREB/ATF family members partially localize to the Golgi [28]. It will
be interesting to analyze their role in the regulation of GOLPH3 transcription.
It has been suggested that Golgi growth is modulated by a “cell growth checkpoint” at late G1
phase, whereby cell growth signals delivered by S6K1 would control the accumulation of some Golgi
proteins and therefore Golgi size [4]. Our data suggests an additional layer of regulatory mechanism
for Golgi growth by identifying a transcriptional mechanism regulating GOLPH3 expression in G1.
Importantly, the delay in G1 to S progression after GOLPH3 depletion that we have observed suggests
the existence of a “Golgi growth checkpoint”, which may impair cell cycle progression if cells are
expressing suboptimal amounts of Golgi proteins. Further research is needed to define the mechanism
for this regulation.
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